Identification of NQO1 and GSTs genotype frequencies in Bulgarian patients with Balkan endemic nephropathy

Journal of Nephrology

Volumn 17, Issue 3, 2004, Pages 384-389

  Toncheva, Draga I ^a   Von Ahsen, Nicolas ^b   Atanasova, Srebrena Y ^a   Dimitrov, Tzvetan G ^a   Armstrong, Victor W ^b   Oellerich, Michael ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Balkan endemic nephropathy; GSTM1; GSTT1; NQO1

Indexed keywords

FLUORESCENT DYE; GLUTATHIONE TRANSFERASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ADULT; AGED; ALLELE; ARTICLE; BULGARIA; CONTROLLED STUDY; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTERSTITIAL NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MELTING POINT; MOLECULAR PROBE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; STATISTICAL SIGNIFICANCE;

BALKAN NEPHROPATHY; BULGARIA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 4243087017     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Brockmoller J, Cascorbi I, Henning S, Meisel C, Roots I. Molecular genetics of cancer susceptibility. Pharmacology 2000; 61: 212-27.
2. Stefanivić V. Balkan endemic nephropathy: a need for novel aetiological approaches. QJ Med 1998; 91: 457-63.
3. Toncheva D, Dimitrov Tz, Stoyanova S. Etiology of Balkan endemic nephropathy: a multifactorial disease. Eur J Epidemiol 1998; 14: 389-94.
4. Ross D, Kepa JK, Winski SL, Beall HD, Anwar A, Siegel D. NAD (P) H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem Biol Interact 2000; 129: 77-97.
5. Delbanco EH, Bolt HM, Huber WW, Beken S, Geller F, Philippou S, Brands FH, Bruning T, Thier R. Glutathione transferase activities in renal carcinomas and adjacent normal renal tissues: factors influencing renal carcinogenesis induced by xenobiotics. Arch Toxicol 2001; 74: 688-94.
6. Siegel D, McGuinness SM, Winski SL, Ross D. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase. Pharmacogenetics 1999; 9: 113-21.
7. Gaedigk A, Tyndale RF, Jurima-Romet M, Sellers EM, Grant DM, Leeder JS. NAD(P)H:quinone oxidoreductase: polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populations. Pharmacogenetics 1998; 8: 305-13.
8. Smith MT. Benzene, NQO1, and genetic susceptibility to cancer. Proc Natl Acad Sci USA 1999; 96: 7624-6.
9. Kempkes M, Golka K, Reich S, Reckwitz T, Bolt HM. Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder. Arch Toxicol 1996; 71: 123-6.
10. Hirvonen A. Genetic factors in individual responses to environmental exposures. J Occup Environ Med 1995; 37: 37-43.
11. Lin HJ, Han CY, Bernstein DA, Hsiao W, Lin BK , Hardy S. Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis 1994; 15: 1077-81.
12. Longuemaux S, Delomenie C, Gallon C, Mejean A, Vincent-Viry M, Bouvier R, Droz D, Krishnamoorthy R, Galteau MM, Junien C, Beroud C, Dupret JM. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes. Cancer Res 1999; 59: 2903-8.
13. Schulz WA, Krummeck A, Rosinger I, Eickelmann P, Neuhaus C, Ebert T, Schmitz-Drager BJ, Sies H. Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies. Pharmacogenetics 1997; 7: 235-9.
14. Miller S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
15. von Ahsen N, Oellerich M, Armstrong VW, Schütz E. Application of a thermodynamic nearest-neighbor model to estimate nucleic acid stability and optimize probe design: prediction of melting points of multiple mutations of apolipoprotein B-3500 and factor V with a hybridization probe genotyping assay on the LightCycler. Clin Chem 1999; 45: 2094-101.
16. Ko Y, Koch B, Harth V, Sachinidis A, Thier R, Vetter H, Bolt HM, Bruning T. Rapid analysis of GSTM1, GSTT1 and GSTP1 polymorphisms using real-time polymerase chain reaction. Pharmacogenetics 2000; 10: 271-4.
17. Breslow N. Day N. Statistical Methods in cancer research. The analysis of case-control studies. IARC Scientific Publ. No 32 Lyon, France: IARC 1980.
18. Abramson J, Gahlinger P. Computer programs for Epidemiologists: PEPI Version 3. Llanindloes, Powys, Wales: Brixton Books 1999.
19. Orem W, Feder G, Finkelnman R. A possible link between Balkan endemic nephropathy and the leaching of toxic organic compounds from pliocene lignites by groundwater. Int J Coal Geol 1999; 40: 237-52.
20. Sarueva R, Horvath A, Andonova I, Yaneva V, Genova J, Regina N, Petrov P, Feaster S, Valeri A, Simeonov V, Petropoulos E, Ganev V. Association of common genetic variants of xenobiotic metabolizing enzymes (CYPs and GSTs) with Balkan endemic nephropathy: A study in the Vratza's district of Bulgaria. (Abstract). Facta Universitatis 2002; 9: 126.